Purchase Order 75N93023P01290

Award Date 9/19/23
Potential Completion Date 9/14/24
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Pleasanton, CA 94588, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $12,306.50 firm fixed-price purchase order to 10X Genomics, Inc., located in Pleasanton, California, to provide Chromium Kits. The contract period of performance runs from August 28, 2023 through August 27, 2024. 10X Genomics will deliver its Chromium Kits to support the NIH's research efforts in the areas of allergy and infectious disease. No...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $23,569.50 firm fixed-price purchase order to 10X Genomics, Inc. for Chromium Kits. The place of performance is Pleasanton, California and the period of performance is from September 19, 2023 through September 18, 2024. This contract has a total small business set-aside designation. 10X Genomics will provide their Chromium Kits to support the National...
10X Genomics, Inc. has been awarded a firm fixed price purchase order valued at fourteen thousand two hundred forty-four dollars and fifty cents ($14,244.50) by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases. The award is for Chromium Kits to be provided by 10X Genomics' Pleasanton, California location by December 30, 2023. As a prime contractor specializing in single-cell and spatial analysis products, 10X...
10X Genomics, Inc. was awarded a $24,324 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide Chromium Kits. As a small business set-aside, this contract supports the NIH/NIAID's research efforts through the delivery of 10X Genomics' genomic analysis products. Performance will occur at the prime contractor's Pleasanton, California facility over a one year period...
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $24,799 firm fixed price purchase order to 10X Genomics, Inc. for Chromium Kits. 10X Genomics, located in Pleasanton, California, will provide their genomic analysis kits to support NIH research efforts from September 2023 through September 2024. The National Institute of Allergy and Infectious Diseases conducts and supports basic and applied research to...
10X Genomics, Inc., doing business as 10X Genomics, has been awarded a $25,000 purchase order contract by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases to deliver chromium reagent kits. Performance will take place in Pleasanton, California over approximately two months, from September 2023 through November 2023. The firm fixed price contract supports NIAID's research efforts through the delivery of the specified...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $22,167.50 firm fixed-price purchase order to 10X Genomics, Inc. for chromium and library construction kits. The place of performance is Pleasanton, California, and the period of performance is August 24, 2023 through October 2, 2023. 10X Genomics will deliver the requested kits to support the NIH NIAID's research efforts. No major subcontractors or set...
10X Genomics, Inc., doing business as 10X Genomics, has been awarded a firm fixed price purchase order valued at $24,999 by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to deliver a CHROMIUM NEXT GEM KIT and a 3' CELLPLEX KIT. Performance will take place in Pleasanton, California over approximately six weeks concluding in late October 2023. The products are being acquired to support research programs at the NIH aimed at advancing understanding of...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $30,539 firm fixed price purchase order to 10X Genomics, Inc. for the acquisition of Chromium Next GEM Single Cell 5' Kits and Library Construction Kits. Under the terms of the contract, 10X Genomics will provide 16 reactions of the Chromium Next GEM Single Cell 5' Kit v2 and 48 reactions of the Library Construction Kit. The place of performance is 10X...
10X Genomics, Inc., doing business as 10X Genomics, has been awarded a $25,000 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to deliver CHROMIUN NEXT GEM reagents and library construction kits. The products will support NIAID's infectious disease research efforts. Performance will take place in Pleasanton, California over approximately two months concluding in late November 2023. No set aside designation or...

10X Genomics, Inc., doing business as 10X Genomics, has been awarded a $15,441.50 firm fixed price purchase order contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide Chromium Kits. Place of performance will be 10X Genomics' facilities in Pleasanton, California. The contract period runs from September 19, 2023 through September 14, 2024. This contract has been set aside for total small business participation. No major subcontractors were identified. The National Institute of Allergy and Infectious Diseases supports research on preventing, diagnosing and treating infectious and immune-mediated diseases through both extramural and intramural programs.

Generated 12/23/23, 1:28 AM